サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1171133

医療バイオミメティクスの世界市場 - 市場規模、シェア、動向分析：タイプ別、用途別、地域別、セグメント予測（2022年～2030年）

Medical Biomimetics Market Size, Share & Trends Analysis Report By Type (Cardiovascular, Orthopedic, Ophthalmology), By Application (Wound Healing, Tissue Engineering, Drug Delivery), By Region, And Segment Forecasts, 2022 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
医療バイオミメティクスの世界市場 - 市場規模、シェア、動向分析：タイプ別、用途別、地域別、セグメント予測（2022年～2030年）
出版日: 2022年11月08日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の医療バイオミメティクスの市場規模は、2030年までに522億米ドルに達し、予測期間中にCAGRで6.7%の成長が予測されています。

ナノテクノロジーの進歩、人工関節やインプラントに対する需要の増加、医療バイオミメティクスに関連する研究開発活動の増加、主要市場企業の戦略的活動などが、市場成長を促進する可能性のある主な要因となっています。

当レポートでは、世界の医療バイオミメティクス市場について調査分析し、市場の動向、セグメント分析、地域分析、競合分析などを提供しています。

目次

第1章 調査手法

第2章 市場の定義

第3章 エグゼクティブサマリー

  • 市場の概要

第4章 世界の医療バイオミメティクス市場の変数、動向、範囲

  • 医療バイオミメティクス市場の系統の見通し
    • 親市場の見通し
  • 浸透と成長の見通しのマッピング
  • 市場促進要因の分析
  • 市場抑制要因の分析
  • 主な機会
  • 医療バイオミメティクス市場 - PESTLE分析
  • 業界分析 - ポーターのファイブフォース分析
  • 主な取引と戦略的提携の分析
    • 合弁事業
    • 合併と買収
    • ライセンシングとパートナーシップ
    • 技術協力
    • 戦略的売却
  • COVID-19の影響の分析

第5章 医療バイオミメティクス市場 - セグメント分析：タイプ別（2018年～2030年）

  • 世界の医療バイオミメティクス市場：製品の変動の分析
  • 心血管
  • 整形外科
  • 眼科
  • 歯科
  • その他

第6章 医療バイオミメティクス市場 - セグメント分析：用途別（2018年～2030年）

  • 医療バイオミメティクス市場：用途の変動の分析
  • 創傷治癒
  • 組織工学
  • ドラッグデリバリー
  • その他の用途

第7章 医療バイオミメティクス市場 - セグメント分析：地域別（2018年～2030年）

  • 医療バイオミメティクス市場：地域の変動の分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 競合情勢

  • 公開会社
    • 企業の市場ポジションの分析
    • 競合ダッシュボード分析
    • 戦略的枠組み
  • 非公開会社
    • 主な新興企業/テクノロジーディスラプター/イノベーターのリスト
    • 地域ネットワークマップ
  • 企業プロファイル
    • OTSUKA MEDICAL DEVICES GROUP
    • STRYKER
    • ABBOTT
    • AVINENT SCIENCE AND TECHNOLOGY
    • SYNTOUCH INC
    • OSTEOPORE INTERNATIONAL PTE LTD
    • VANDSTROM, INC.
    • BIOMIMETICS TECHNOLOGIES INC
    • SWEDISH BIOMIMETICS 3000 APS
    • LIFEMATRIX
    • KEYSTONE DENTAL GROUP
    • CURASAN, INC.
    • CORNEAT VISION
    • NANOHIVE MEDICAL LLC
    • ZIMMER BIOMET
図表

List of Tables

  • TABLE 1 List of Secondary Sources
  • TABLE 2 List of Abbreviations
  • TABLE 3 Global Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 4 Global Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 5 Global Medical biomimetics market, by Region, 2018 - 2030 (USD Million)
  • TABLE 6 North America Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 7 North America Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 8 North America Medical biomimetics market, by Country, 2018 - 2030 (USD Million)
  • TABLE 9 U.S. Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 10 U.S. Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 11 Canada Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 12 Canada Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 13 Europe Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 14 Europe Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 15 Europe Medical biomimetics market, by Country, 2018 - 2030 (USD Million)
  • TABLE 16 Germany Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 17 Germany Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 18 U.K. Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 19 U.K. Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 20 France Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 21 France Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 22 Spain Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 23 Spain Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 24 Italy Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 25 Italy Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 26 Asia Pacific Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 27 Asia Pacific Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 28 Asia Pacific Medical biomimetics market, by Country, 2018 - 2030 (USD Million)
  • TABLE 29 China Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 30 China Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 31 Japan Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 32 Japan Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 33 India Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 34 India Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 35 South Korea Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 36 South Korea Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 37 Australia Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 38 Australia Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 39 Latin America Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 40 Latin America Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 41 Latin America Medical biomimetics market, by Country, 2018 - 2030 (USD Million)
  • TABLE 42 Brazil Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 43 Brazil Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 44 Mexico Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 45 Mexico Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 46 Argentina Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 47 Argentina Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 48 Middle East & Africa Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 49 Middle East & Africa Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 50 Middle East & Africa Medical biomimetics market, by Country, 2018 - 2030 (USD Million)
  • TABLE 51 South Africa Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 52 South Africa Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 53 Saudi Arabia Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 54 Saudi Arabia Medical biomimetics market, by Application, 2018 - 2030 (USD Million)
  • TABLE 55 UAE Medical biomimetics market, by Type, 2018 - 2030 (USD Million)
  • TABLE 56 UAE Medical biomimetics market, by Application, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary Research Pattern
  • FIG. 4 Market Research Approaches
  • FIG. 5 Value Chain-Based Sizing & Forecasting
  • FIG. 6 Market Formulation & Validation
  • FIG. 7 Medical Biomimetics Market Segmentation
  • FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
  • FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
  • FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
  • FIG. 11 Penetration & Growth Prospect Mapping
  • FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • FIG. 13 Porter's Five Forces Analysis
  • FIG. 14 Market Penetration Vs Growth Prospect Mapping, 2021
  • FIG. 15 Global Medical Biomimetics Market, for, Cardiovascular 2018 - 2030 (USD Million)
  • FIG. 16 Global Medical Biomimetics Market, for, Orthopedic 2018 - 2030 (USD Million)
  • FIG. 17 Global Medical Biomimetics Market, for, Ophthalmology 2018 - 2030 (USD Million)
  • FIG. 18 Global Medical Biomimetics Market, for, Dental 2018 - 2030 (USD Million)
  • FIG. 19 Global Medical Biomimetics Market, for, Other Types 2018 - 2030 (USD Million)
  • FIG. 20 Global Medical Biomimetics Market, for, Wound Healing
  • FIG. 21 Global Medical Biomimetics Market, for, Tissue Engineering
  • FIG. 22 Global Medical Biomimetics Market, for, Drug Delivery
  • FIG. 23 Global Medical Biomimetics Market, for, Other Applications
  • FIG. 24 Regional Marketplace: Key Takeaways
  • FIG. 25 Regional Outlook, 2021 & 2030
  • FIG. 26 Global Medical Biomimetics Market: Region Movement Analysis
  • FIG. 27 North America Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 28 U.S. Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 29 Canada Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 30 Europe Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 31 Germany Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 32 UK Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 33 France Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 34 Spain Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 35 Italy Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 36 Asia Pacific Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 37 Japan Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 38 China Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 39 India Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 40 Australia Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 41 South Korea Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 42 Latin America Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 43 Brazil Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 44 Argentina Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 45 Mexico Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 46 Middle East and Africa Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 47 South Africa Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 48 Saudi Arabia Medical Biomimetics Market, 2018 - 2030 (USD Million)
  • FIG. 49 UAE Medical Biomimetics Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-995-0

Medical Biomimetics Market Growth & Trends:

The global medical biomimetics market size is expected to reach USD 52.2 billion by 2030, registering a CAGR of 6.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing advancement in nanotechnology, increasing demand for prostheses and implant, rise in R&D activities associated with medical biomimetics and strategic activities by key market players are the major factors which are likely to drive the market growth. For instance, in April 2021, curasan AG expanded its distribution network in Europe, the company has added Silesia Dental and Implants Diffusion International SARL to its European distribution network.

Diseases affecting the cornea are most important cause of blindness across the globe. According to the WHO, around 2 million new cases of corneal blindness are reported every year. More than 30 million people across the globe are blind in one or both eyes from corneal disease and injury, while several suffer from degraded visual acuity. Numerous attempts to create reliable, robust, and scalable solutions for artificial cornea have been unsuccessful. As such, there exists an unmet need, the research and development activities are being carried out for affordable and long-lasting solutions for pathology, injury, and corneal blindness. For instance, in March 2022, researchers from the Centre for LV Prasad Eye Institute, IIT-Hyderabad and Cellular, and Molecular Biology developed an exclusive biomimetic corneal hydrogel, manufactured from discarded human corneas, which can be used for the treatment of corneal scarring, the main cause of corneal blindness.

Numerous companies in the medical biomimetics market are expanding their products in emerging markets. For instance, a most important new development, in November 2021, Osteopore has been granted a patent in China for its smart 3D biometric scaffolds. The technology was developed with scientists from NTU Singapore and was previously granted a European patent in early 2021. This patent is anticipated to create numerous research and development opportunities in the Chinese market and allows the company to tap into local expertise as part of its product advancement process.

The COVID-19 pandemic is anticipated to negatively impact the medical biomimetics market growth. The COVID-19 pandemic had a considerable effect on the number of patients looking for dental treatments. The overall reduction in the number of patients treated in the Hospitals in Jordan was about 90.4% (17,591 to 1689). As a result, the usage of these technologies was less during the COVID-19 pandemic.

Furthermore, with the escalating number of accidents, the implementation of biomimetics for orthopedics is projected to boom. According to Association for Safe International Road Travel, every year about 20 to 50 million people worldwide suffer from injuries that leads to permanent disability. Hence, such factors are estimated to impact positively the growth of the medical biomimetics market.

On the other hand, a stringent regulatory framework hinders the medical biomimetics industry's growth. Regarding the ever-increasing and widespread applications of biomimetic biomaterials in numerous medical fields, their precise assessment is of great significance. Although each biomaterial undergoes thorough premarket evaluation, the regulatory organizations receive a significant number of adverse event and complications reports each year. Moreover, biomaterials are integrated into biological systems, hence, they must fulfill all scientific requirements such as high biocompatibility, sufficiently long shelf-life, and accommodating biological interactions.

Medical Biomimetics Market Report Highlights:

  • By type, the cardiovascular segment held the largest share of the medical biomimetics market. This is attributed to the increasing research activities and rising cases of cardiovascular diseases which in turn is likely to increase the adoption of biomimetics and anticipate the medical biomimetics market growth
  • The wound healing segment is expected to grow exponentially over the forecast period. The demand for wound healing and wound care products is growing owing to the escalating number of surgical cases and the increasing prevalence of chronic diseases globally
  • The drug delivery segment of the medical biomimetics market is anticipated to grow at the fastest rate due to crucial developments in nanotechnology that have facilitated efficient and accurate non-carrier drug delivery using biomimetics based devices. Adequate funding and advancements in research and development will boost the medical biomimetics market growth
  • North America dominated the global medical biomimetics market in 2021 due to the high R&D investment, development of novel products, and strong funding from the government in the region
  • The Asia Pacific is expected to grow significantly in the future owing to the expansion of business by key market players along with the increasing prevalence of chronic disorders
  • A few of the key medical biomimetics market players include Otsuka Medical Devices Group, Stryker, Abbott, AVINENT Science and Technology, SynTouch Inc, Osteopore International Pte Ltd, and others

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Solutionology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity flow approach
      • 1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
  • 1.7 Global Market: CAGR Calculation
  • 1.8 Research Assumptions
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1
    • 1.11.2 Objective 2
  • 1.12 List Of Abbreviations

Chapter 2 Market Definitions

Chapter 3 Executive Summary

  • 3.1 Market Summary

Chapter 4 Global Medical Biomimetics Market Variables, Trends, & Scope

  • 4.1 Medical Biomimetics Market Lineage Outlook
    • 4.1.1 Parent Market Outlook
  • 4.2 Penetration and Growth Prospect Mapping
  • 4.3 Market Driver Analysis
    • 4.3.1 Growing Advancement In Nanotechnology
    • 4.3.2 Increasing Demand For Prostheses And Implants
    • 4.3.3 Rise In Research And Development Activities Associated With Medical Biomimetics
  • 4.4 Market Restraint Analysis
    • 4.4.1 Stringent Regulatory Framework
  • 4.5 Key Opportunities
    • 4.5.1 Growing Tissue Engineering Market
  • 4.6 Medical Biomimetics Market - Pestle Analysis
  • 4.7 Industry Analysis - Porter's
  • 4.8 Major Deals And Strategic Alliances Analysis
    • 4.8.1 Joint Ventures
    • 4.8.2 Mergers And Acquisitions
    • 4.8.3 Licensing And Partnership
    • 4.8.4 Technology Collaborations
    • 4.8.5 Strategic Divestments
  • 4.9 COVID-19 Impact Analysis

Chapter 5 Medical Biomimetics Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

  • 5.1 Global Medical Biomimetics Market: Product Movement Analysis
  • 5.2 Cardiovascular
    • 5.2.1 Cardiovascular Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Orthopedic
    • 5.3.1 Orthopedic Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Ophthalmology
    • 5.4.1 Ophthalmology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Dental
    • 5.5.1 Dental Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Medical Biomimetics Market- Segment Analysis, By Application, 2018 - 2030 (Usd Million)

  • 6.1 Medical Biomimetics Market: Application Movement Analysis
  • 6.2 Wound Healing
    • 6.2.1 Wound Healing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Tissue Engineering
    • 6.3.1 Tissue Engineering Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Drug Delivery
    • 6.4.1 Drug Delivery Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.5 Other Applications
    • 6.5.1 Other Applications Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Medical Biomimetics Market: - Segment Analysis, by Region, 2018 - 2030 (USD Million)

  • 7.1 Medical Biomimetics Market: Regional Movement Analysis
  • 7.2 North America
    • 7.2.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.3.2 U.K.
      • 7.3.2.1 Uk Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1 Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India Market Estimates And Forecast, 2018-2030
    • 7.4.5 South Korea
      • 7.4.5.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.6 Australia
      • 7.4.6.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America Market Estimates AND FORECAST, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 Middle East & Africa (Mea)
    • 7.6.1 Middle East & Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.6.4 Uae
      • 7.6.4.1 Uae Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Public Companies
    • 8.1.1 Company Market Position Analysis
    • 8.1.2 Competitive Dashboard Analysis
    • 8.1.3 Strategic Framework
  • 8.2 Private Companies
    • 8.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
    • 8.2.2 Regional Network Map
  • 8.3 Company Profiles
    • 8.3.1 OTSUKA MEDICAL DEVICES GROUP
      • 8.3.1.1 Company Overview
      • 8.3.1.2 Financial Performance
      • 8.3.1.3 Product Benchmarking
      • 8.3.1.4 Strategic Initiatives
    • 8.3.2 STRYKER
      • 8.3.2.1 Company Overview
      • 8.3.2.2 Financial Performance
      • 8.3.2.3 Product Benchmarking
      • 8.3.2.4 Strategic Initiatives
    • 8.3.3 ABBOTT
      • 8.3.3.1 Company Overview
      • 8.3.3.2 Financial Performance
      • 8.3.3.3 Product Benchmarking
      • 8.3.3.4 Strategic Initiatives
    • 8.3.4 AVINENT SCIENCE AND TECHNOLOGY
      • 8.3.4.1 Company Overview
      • 8.3.4.2 Financial Performance
      • 8.3.4.3 Product Benchmarking
      • 8.3.4.4 Strategic Initiatives
    • 8.3.5 SYNTOUCH INC
      • 8.3.5.1 Company Overview
      • 8.3.5.2 Financial Performance
      • 8.3.5.3 Product Benchmarking
      • 8.3.5.4 Strategic Initiatives
    • 8.3.6 OSTEOPORE INTERNATIONAL PTE LTD
      • 8.3.6.1 Company Overview
      • 8.3.6.2 Financial Performance
      • 8.3.6.3 Product Benchmarking
      • 8.3.6.4 Strategic Initiatives
    • 8.3.7 VANDSTROM, INC.
      • 8.3.7.1 Company Overview
      • 8.3.7.2 Financial Performance
      • 8.3.7.3 Product Benchmarking
      • 8.3.7.4 Strategic Initiatives
    • 8.3.8 BIOMIMETICS TECHNOLOGIES INC
      • 8.3.8.1 Company Overview
      • 8.3.8.2 Financial Performance
      • 8.3.8.3 Product Benchmarking
      • 8.3.8.4 Strategic Initiatives
    • 8.3.9 SWEDISH BIOMIMETICS 3000 APS
      • 8.3.9.1 Company Overview
      • 8.3.9.2 Financial Performance
      • 8.3.9.3 Product Benchmarking
      • 8.3.9.4 Strategic Initiatives
    • 8.3.10 LIFEMATRIX
      • 8.3.10.1 Company Overview
      • 8.3.10.2 Financial Performance
      • 8.3.10.3 Product Benchmarking
      • 8.3.10.4 Strategic Initiatives
    • 8.3.11 KEYSTONE DENTAL GROUP
      • 8.3.11.1 Company Overview
      • 8.3.11.2 Financial Performance
      • 8.3.11.3 Product Benchmarking
      • 8.3.11.4 Strategic Initiatives
    • 8.3.12 CURASAN, INC.
      • 8.3.12.1 Company Overview
      • 8.3.12.2 Financial Performance
      • 8.3.12.3 Product Benchmarking
      • 8.3.12.4 Strategic Initiatives
    • 8.3.13 CORNEAT VISION
      • 8.3.13.1 Company Overview
      • 8.3.13.2 Financial Performance
      • 8.3.13.3 Product Benchmarking
      • 8.3.13.4 Strategic Initiatives
    • 8.3.14 NANOHIVE MEDICAL LLC
      • 8.3.14.1 Company Overview
      • 8.3.14.2 Financial Performance
      • 8.3.14.3 Product Benchmarking
      • 8.3.14.4 Strategic Initiatives
    • 8.3.15 ZIMMER BIOMET
      • 8.3.15.1 Company Overview
      • 8.3.15.2 Financial Performance
      • 8.3.15.3 Product Benchmarking
      • 8.3.15.4 Strategic Initiatives